Sotsiaalministeerium · 16. jaanuar 2021
- Viit
- 1.4-2/155-1
- Registreeritud
- 16. jaanuar 2021
- Dokumendi liik
- Väljaminev kiri
- Adressaat
- S. K.
- Saabumis/saatmisviis
- Outlook
- Funktsioon
- 1.4 EL otsustusprotsess ja rahvusvaheline koostöö
- Sari
- 1.4-2 Rahvusvahelise koostöö korraldamisega seotud kirjavahetus (Arhiiviväärtuslik)
- Toimik
- 1.4-2/2021
- Vastutaja
- Eva Lehtla (Sotsiaalministeerium, Kantsleri vastutusvaldkond, Kommunikatsiooniosakond)
Sisu (failidest)
January 15, 2021
Mrs. Stella Kyriakides
Commissioner for Health and Food Safety
Dear Stella,
We are writing to You with severe concern about the sustainability and credibility
of the COVID-19 vaccination process, following the oral announcements of
BioNTech/Pfizer representatives about their delivery difficulties.
We commend the work You, Your team and the entire European Commission did in
intensively establishing the mechanism of Joint Procurement of the Covid-19
vaccines. Estonia, Finland, Latvia, Lithuania, Denmark and Sweden among all other
EU Member States are committed to the Joint Mechanism, timely responded to
APAs, and contributed to top-up the ESI as requested. Our solidarity and joint work
on rollout of vaccines gave an optimism in the entire European Union.
While still having a very difficult situation with a pandemic in the countries, we have
a clear vaccination strategy and precise plan to vaccinate concrete risk groups in the
coming days, weeks and months.
Therefore, we were and still are looking for the increase of the vaccines production
and deliveries from BioNTech/Pfizer after the European Commission successfully
secured additional 300 mln. doses of vaccines from new incoming BioNTech/Pfizer
facilities within the EU.
However, officials responsible for vaccination in our countries were informed by
BioNTech/Pfizer local representatives that delivery to our countries will be
substantially reduced in the coming weeks, some were given the deadline of
February 8, 2021, some were given no information on the duration of the intended
decreased deliveries.
We are obliged to inform our public and the particular risk groups (persons), that
their vaccination will be delayed, regardless of the outstanding efforts by our
Governments to ensure their timely delivery. This situation is unacceptable. Not only
1
does it impact the planned vaccination schedules, it also decreases the credibility of
the vaccination process.
We request You to urgently engage with BioNTech/Pfizer to demand a public
explanation of the situation and to stress the need to ensure stability and transparency
of timely deliveries. National Governments cannot plan for successful vaccination
without predictability of the vaccine delivery schedules.
We believe in Your capability to help the Member States in this complicated
situation with equally strong determination with which You have led the process so
far.
Sincerely,
Mr. Arūnas Dulkys Mr. Daniels Pavļuts
Minister of Health of the Republic of Minister for Health of the Republic of
Lithuania Latvia
Mr. Tanel Kiik Ms. Krista Kiuru
Minister of Social Affairs of the Minister of Family Affairs and Social
Republic of Estonia Services, Finland
Mr. Magnus Heunicke
Minister for Health and Senior Citizens Ms. Lena Hallengren
of Denmark Minister for Health
Of Sweden
2